Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy
Go back to Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 33.21 +1.01 (3.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.20 | 52 Week High | $66.55 | |||
| Open | $32.14 | 52 Week Low | $37.82 | |||
| Day High | $33.34 | P/E | N/A | |||
| Day Low | $32.12 | EPS | $0.00 | |||
| Volume | 5,567,042 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 33.21 +1.01 (3.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.20 | 52 Week High | $66.55 | |||
| Open | $32.14 | 52 Week Low | $37.82 | |||
| Day High | $33.34 | P/E | N/A | |||
| Day Low | $32.12 | EPS | $0.00 | |||
| Volume | 5,567,042 | |||||
